OZEMPIC® 1mg (Polish)

• Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
  • in addition to other medicinal products for the treatment of diabetes.

• OZEMPIC® is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as:
  • an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.

• Active Ingredient: semaglutide
• Inactive Ingredients:
  • disodium phosphate dihydrate
  • propylene glycol
  • phenol
  • hydrochloric acid
  • sodium hydroxide
  • water for injections

Contraindications

• Personal or family history of MTC or in patients with MEN 2.
• Serious hypersensitivity reaction to semaglutide or any of the excipients in OZEMPIC®.
• Females and Males of Reproductive Potential: Discontinue OZEMPIC® in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide.

After-care

• Store your pen in use for 56 days at room temperature between 59ºF to 86ºF (15ºC to 30ºC) or in a refrigerator between 36°F to 46°F (2°C to 8°C). Use OZEMPIC® 1 time each week, on the same day each period, at any time of the day.
• You may change the set day on which you use OZEMPIC® as long as your last dosage was given 2 or more days before.
• If you miss a treatment of OZEMPIC®, take the missed dose as soon as possible within 5 days. If more than 5 days have passed, skip the missed dosage and take your next dose on the regularly scheduled day. Check your blood sugar as your health-care provider tells you to.
• Stay on your prescribed diet and exercise program while using OZEMPIC®.
• Talk to your health-care provider about how to prevent, recognize and manage hypoglycemia, hyperglycemia, and problems you have because of your diabetes.
• Your health-care provider will check your diabetes with regular blood tests, including your blood sugar levels and your hemoglobin A1C.
• Do not share your OZEMPIC® pen with other people, even if the injection tip has been changed. You may give other people a serious infection, or get a serious infection from them.